Gambaran Umum
Scancell Holdings plc, based in the United Kingdom, operates primarily in the biotechnology sector, focusing on the development of novel immunotherapies for cancer. The company is at the forefront of leveraging the body's immune system to tackle various cancer types, endorsing projects that emphasize innovative vaccine platforms and antibody treatments. Key projects include its ImmunoBody® and Moditope® platforms, which inspire distinctive immune responses, capable of destroying tumors with high precision. Scancell's clinical programs, particularly in melanoma and other solid tumors, aim to revolutionize treatment paradigms and improve patient outcomes. The company continues to advance its portfolio through rigorous scientific research and strategic collaborations to enhance therapeutic efficacy and commercial viability.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Scancell Holdings plc per 2024 Oct 31 adalah -20.69 MM.
- Nilai net income untuk Scancell Holdings plc per 2024 Oct 31 adalah -15.81 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2024-10-31 | -20.69 | -15.81 | |
2024-07-31 | -19.48 | -10.84 | |
2024-04-30 | -18.27 | -5.86 | |
2024-01-31 | 0.00 | -18.17 | -7.69 |
2023-10-31 | 0.00 | -18.07 | -9.53 |
2023-07-31 | 2.64 | -14.99 | -10.73 |
2023-04-30 | 5.27 | -11.92 | -11.94 |
2023-01-31 | 5.27 | -11.38 | -12.33 |
2022-10-31 | 5.27 | -10.84 | -12.73 |
2022-07-31 | 2.64 | -12.55 | -8.65 |
2022-04-30 | -14.26 | -4.57 | |
2022-01-31 | -13.22 | -6.49 | |
2021-10-31 | -12.17 | -8.41 | |
2021-07-31 | -10.96 | -11.95 | |
2021-04-30 | -9.75 | -15.48 | |
2021-01-31 | -8.21 | -11.17 | |
2020-10-31 | -6.67 | -6.85 | |
2020-07-31 | |||
2020-04-30 |
Laporan Laba Rugi: EPS
- earnings per share basic untuk Scancell Holdings plc pada 2024 Oct 31 adalah -0.02.
- laba per saham yang terdilusi untuk Scancell Holdings plc pada 2024 Oct 31 adalah -0.02.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2024-10-31 | -0.02 | -0.02 |
2024-07-31 | -0.01 | -0.02 |
2024-04-30 | -0.01 | -0.01 |
2024-01-31 | -0.01 | -0.01 |
2023-10-31 | -0.01 | -0.02 |
2023-07-31 | -0.01 | -0.02 |
2023-04-30 | -0.01 | -0.02 |
2023-01-31 | -0.02 | -0.02 |
2022-10-31 | -0.02 | -0.02 |
2022-07-31 | -0.01 | -0.01 |
2022-04-30 | -0.01 | -0.01 |
2022-01-31 | -0.01 | -0.01 |
2021-10-31 | -0.01 | -0.01 |
2021-07-31 | -0.02 | -0.02 |
2021-04-30 | -0.02 | -0.02 |
2021-01-31 | -0.02 | -0.02 |
2020-10-31 | -0.01 | -0.01 |
2020-07-31 | -0.01 | -0.01 |
2020-04-30 | -0.01 | -0.01 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Scancell Holdings plc per 2024 Oct 31 adalah -13.82 MM.
- Nilai cash from investing activities untuk Scancell Holdings plc per 2024 Oct 31 adalah -0.01 MM.
- Nilai kas dari aktivitas pendanaan untuk Scancell Holdings plc per 2024 Oct 31 adalah 9.92 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2024-10-31 | -13.82 | -0.01 | 9.92 |
2024-07-31 | -14.74 | 0.09 | 10.15 |
2024-04-30 | -15.66 | 0.18 | 10.39 |
2024-01-31 | -13.10 | 0.24 | 4.84 |
2023-10-31 | -10.54 | 0.30 | -0.72 |
2023-07-31 | -9.34 | 0.19 | -0.73 |
2023-04-30 | -8.14 | 0.08 | -0.75 |
2023-01-31 | -9.06 | -0.24 | -0.87 |
2022-10-31 | -9.98 | -0.56 | -0.99 |
2022-07-31 | -10.09 | -0.91 | -0.96 |
2022-04-30 | -10.19 | -1.26 | -0.93 |
2022-01-31 | -9.66 | -1.33 | 9.71 |
2021-10-31 | -9.13 | -1.39 | 20.35 |
2021-07-31 | -8.47 | -1.07 | 33.22 |
2021-04-30 | -7.80 | -0.74 | 46.08 |
2021-01-31 | -6.64 | -0.44 | 35.82 |
2020-10-31 | -5.47 | -0.13 | 25.56 |
2020-07-31 | |||
2020-04-30 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2024-10-31 | |||
2024-07-31 | |||
2024-04-30 | |||
2024-01-31 | |||
2023-10-31 | |||
2023-07-31 | |||
2023-04-30 | |||
2023-01-31 | |||
2022-10-31 | |||
2022-07-31 | |||
2022-04-30 | |||
2022-01-31 | |||
2021-10-31 | |||
2021-07-31 | |||
2021-04-30 | |||
2021-01-31 | |||
2020-10-31 | |||
2020-07-31 | |||
2020-04-30 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2024-10-31 | ||
2024-07-31 | 0.00 | -0.06 |
2024-04-30 | ||
2024-01-31 | ||
2023-10-31 | ||
2023-07-31 | ||
2023-04-30 | ||
2023-01-31 | ||
2022-10-31 | ||
2022-07-31 | ||
2022-04-30 | ||
2022-01-31 | ||
2021-10-31 | ||
2021-07-31 | ||
2021-04-30 | ||
2021-01-31 | ||
2020-10-31 | ||
2020-07-31 | ||
2020-04-30 |
Efektivitas Manajemen
- roa untuk Scancell Holdings plc pada 2024 Oct 31 adalah -0.26.
- roic untuk Scancell Holdings plc pada 2024 Oct 31 adalah -0.32.
- croic untuk Scancell Holdings plc pada 2024 Oct 31 adalah -0.28.
- ocroic untuk Scancell Holdings plc pada 2024 Oct 31 adalah -0.85.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2024-10-31 | -0.26 | -0.32 | -0.28 | -0.85 | |
2024-07-31 | 0.00 | ||||
2024-04-30 | |||||
2024-01-31 | |||||
2023-10-31 | -0.62 | ||||
2023-07-31 | -0.70 | ||||
2023-04-30 | |||||
2023-01-31 | 0.00 | ||||
2022-10-31 | 0.00 | ||||
2022-07-31 | |||||
2022-04-30 | |||||
2022-01-31 | 0.00 | ||||
2021-10-31 | 0.00 | 0.00 | |||
2021-07-31 | -1.76 | -2.02 | -0.44 | 1.07 | -0.22 |
2021-04-30 | -1.76 | -2.02 | -0.40 | 0.98 | -0.20 |
2021-01-31 | -0.60 | -0.64 | -0.24 | 0.71 | -0.19 |
2020-10-31 | -0.54 | -0.58 | -0.22 | 0.34 | -0.18 |
2020-07-31 | -0.54 | -0.58 | -0.22 | 0.34 | -0.18 |
2020-04-30 | -0.52 | -0.59 | -0.71 | -0.13 | -0.61 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2024-10-31 | |||
2024-07-31 | |||
2024-04-30 | |||
2024-01-31 | |||
2023-10-31 | |||
2023-07-31 | -4.07 | -5.69 | |
2023-04-30 | -2.17 | -2.16 | |
2023-01-31 | |||
2022-10-31 | |||
2022-07-31 | |||
2022-04-30 | |||
2022-01-31 | |||
2021-10-31 | |||
2021-07-31 | |||
2021-04-30 | |||
2021-01-31 | |||
2020-10-31 | |||
2020-07-31 | |||
2020-04-30 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) |